Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for B-Cell Maturation Antigen(BCMA) Targeted Therapies are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market segmented into
Bispecific Antibodies
Antibody Drug Conjugates
Chimeric Antigen Receptor T-Cells
Based on the end-use, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market classified into
Liver Cancer
Respiratory Cancer
Brain Cancer
Others
Based on geography, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Transposagen Biopharmaceuticals
Sutro Biopharma
Malin Corporation
Eureka Therapeutics
firstVentury Equity
Five Prime Therapeutics
Credit Suisse Securities
Dana-Farber Cancer Institute
Deerfield Partners
Onyx Pharmaceuticals
Juno Therapeutics
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES INDUSTRY
2.1 Summary about B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry
2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trends
2.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Production & Consumption Trends
2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Structure Trends
2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Bispecific Antibodies
4.2.2 Antibody Drug Conjugates
4.2.3 Chimeric Antigen Receptor T-Cells
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Liver Cancer
4.3.2 Respiratory Cancer
4.3.3 Brain Cancer
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Bispecific Antibodies
5.2.2 Antibody Drug Conjugates
5.2.3 Chimeric Antigen Receptor T-Cells
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Liver Cancer
5.3.2 Respiratory Cancer
5.3.3 Brain Cancer
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Bispecific Antibodies
6.2.2 Antibody Drug Conjugates
6.2.3 Chimeric Antigen Receptor T-Cells
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Liver Cancer
6.3.2 Respiratory Cancer
6.3.3 Brain Cancer
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Bispecific Antibodies
7.2.2 Antibody Drug Conjugates
7.2.3 Chimeric Antigen Receptor T-Cells
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Liver Cancer
7.3.2 Respiratory Cancer
7.3.3 Brain Cancer
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Bispecific Antibodies
8.2.2 Antibody Drug Conjugates
8.2.3 Chimeric Antigen Receptor T-Cells
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Liver Cancer
8.3.2 Respiratory Cancer
8.3.3 Brain Cancer
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Bispecific Antibodies
9.2.2 Antibody Drug Conjugates
9.2.3 Chimeric Antigen Receptor T-Cells
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Liver Cancer
9.3.2 Respiratory Cancer
9.3.3 Brain Cancer
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Transposagen Biopharmaceuticals
10.1.2 Sutro Biopharma
10.1.3 Malin Corporation
10.1.4 Eureka Therapeutics
10.1.5 firstVentury Equity
10.1.6 Five Prime Therapeutics
10.1.7 Credit Suisse Securities
10.1.8 Dana-Farber Cancer Institute
10.1.9 Deerfield Partners
10.1.10 Onyx Pharmaceuticals
10.1.11 Juno Therapeutics
10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Date of Major Players (2017-2020e)
10.2.1 Transposagen Biopharmaceuticals
10.2.2 Sutro Biopharma
10.2.3 Malin Corporation
10.2.4 Eureka Therapeutics
10.2.5 firstVentury Equity
10.2.6 Five Prime Therapeutics
10.2.7 Credit Suisse Securities
10.2.8 Dana-Farber Cancer Institute
10.2.9 Deerfield Partners
10.2.10 Onyx Pharmaceuticals
10.2.11 Juno Therapeutics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Type Overview
2.Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Type Market Share List
3.Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Type of Major Players
4.Table Brief Introduction of Transposagen Biopharmaceuticals
5.Table Brief Introduction of Sutro Biopharma
6.Table Brief Introduction of Malin Corporation
7.Table Brief Introduction of Eureka Therapeutics
8.Table Brief Introduction of firstVentury Equity
9.Table Brief Introduction of Five Prime Therapeutics
10.Table Brief Introduction of Credit Suisse Securities
11.Table Brief Introduction of Dana-Farber Cancer Institute
12.Table Brief Introduction of Deerfield Partners
13.Table Brief Introduction of Onyx Pharmaceuticals
14.Table Brief Introduction of Juno Therapeutics
15.Table Products & Services of Transposagen Biopharmaceuticals
16.Table Products & Services of Sutro Biopharma
17.Table Products & Services of Malin Corporation
18.Table Products & Services of Eureka Therapeutics
19.Table Products & Services of firstVentury Equity
20.Table Products & Services of Five Prime Therapeutics
21.Table Products & Services of Credit Suisse Securities
22.Table Products & Services of Dana-Farber Cancer Institute
23.Table Products & Services of Deerfield Partners
24.Table Products & Services of Onyx Pharmaceuticals
25.Table Products & Services of Juno Therapeutics
26.Table Market Distribution of Major Players
27.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
28.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
29.Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (Million USD) by Region 2021f-2026f
30.Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (Million USD) Share by Region 2021f-2026f
31.Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (Million USD) by Demand 2021f-2026f
32.Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Bispecific Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Antibody Drug Conjugates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Chimeric Antigen Receptor T-Cells Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Liver Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Respiratory Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Bispecific Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Antibody Drug Conjugates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Chimeric Antigen Receptor T-Cells Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Liver Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Respiratory Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Bispecific Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Antibody Drug Conjugates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Chimeric Antigen Receptor T-Cells Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Liver Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Respiratory Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Bispecific Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Antibody Drug Conjugates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Chimeric Antigen Receptor T-Cells Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Liver Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Respiratory Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Bispecific Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Antibody Drug Conjugates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Chimeric Antigen Receptor T-Cells Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Liver Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Respiratory Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Bispecific Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Antibody Drug Conjugates Segmentation Market Size (U
The VoIP Cell Phone Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...
The Alkaline Electrolyte Fuel Cell Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Cell and Gene Therapy CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The DMSO Cell Cryopreservation Medium Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The T Cell Serum-Free Medium Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...
The Serum-Free Unprogrammed Cell Cryopreservation Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, com...
The Rapid Cell Cryopreservation Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Fuel Cell Tour Bus Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/pl...
The Cord Blood Stem Cell Storage Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Solid Oxide Fuel Cell (SOFC) Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...